clinical case of pseudarthrosis of the tibia in patient with neurofibromatosis type i

Clicks: 223
ID: 200737
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #18 of 31 articles by views in journal of applied psychology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The article describes the clinical signs of neurofibromatosis type I, in particular its bone manifestations. Also information on current approaches to diagnosis and surgical treatment of patients with neurofibromatosis type I and pseudarthrosis of the tibia is provided. Comprehensive treatment requires collaboration of experts of various disciplines taking into account that the lesion in neurofibromatosis is polysystemic, multiorgan and multidirectional. The choice of each stage of conservative and surgical treatment to restore the function of the limb should be differentiated. Long rehabilitation period provides social adaptation with proper improvement in the quality of life. Clinical case demonstrates professional use by the authors of treatment strategy resulting in a positive outcome — union of both bones of the tibia and partial recovery of limb function.
Reference Key
mysliborska2014bol,clinical Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Ya.V. Mysliborska
Journal journal of applied psychology
Year 2014
DOI
10.22141/2224-1507.4.16.2014.79877
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.